The FDA states that Pfizer’s vaccine supply is 40 percent higher than before, because the vials contain multiple doses

The Food and Drug Administration (FDA) said Wednesday that health officials may initially be able to obtain seven doses of Pfizer’s coronavirus vaccine from vials to hold just five.

Hospital pharmacists noted the discovery of Twitter and pharmacy message boards this week, as front-line health care workers began receiving the vaccine on Monday.

The FDA officially opened on Wednesday evening. Released a statement on twitter, Knowing that it “knew of some vials of Pfizer-BioNTech.” # COVID-19 The vaccine contains additional products after receiving five doses. “

“At this time, in view of a public health emergency, the FDA is advising that it is acceptable to use every full dose obtainable (VI, or possibly even seventh) from each vial, pending resolution of the issue,” the FDA released in Placed follow-up tweet.

However, the FDA stated that the remaining ingredients should not be combined with multiple vials to make the full dose and that the agency is “working with Pfizer to determine the best path forward, and will share additional updates as our Is near. “

Political trickster First the FDA reported finding additional doses before the public announcement.

According to the news outlet, a federal health official informed the vaccine providers on Wednesday morning that they could use every dose received from a vial. Pfizer knew this change by noon.

Erin Fox, a pharmacy specialist at the University of Utah tracking drug shortages, told POLITICO that pharmaceutical companies overfill vaccine vials in the event of spills and other wastes.

“Completely extra dose or more although this is very unusual – but it seems so!” She said in an email to a news outlet.

Pfizer spokesperson Sharon Castillo told POLITICO on Wednesday that “the amount of vaccine left in a multidose vial after 5 doses is taken may vary, depending on the type of needles and syringes used.”

Pfizer has stated that it has manufactured enough of the vaccine to deliver at least 25 million doses to the United States before the end of the year, enough for 12.5 million people, as the vaccine is given within two weeks of each other. Shots are required.

Federal authorities have already dispensed about 2.9 million doses following FDA’s emergency use approval last week.

Final test data showed Pfizer’s vaccine to be 95 percent effective at preventing COVID-19.

A vaccine candidate developed by Modern, which has a similar efficacy rate, is also being considered for FDA emergency use approval this week.


Leave a Reply

Your email address will not be published.